Show
Sort by
-
Growth, sexual and bone development in a boy with bilateral anorchia under testosterone treatment guided by the development of his monozygotic twin
-
Three year functional changes and long-term mortality hazard in community-dwelling older men
-
Validation of the FNIH sarcopenia criteria and SOF frailty index as predictors of long-term mortality in ambulatory older men
-
- Conference Paper
- C3
- open access
Validation of the Study of Osteoporotic Fractures (SOF) frailty index as predictor of long-term mortality in ambulatory older men
-
- Conference Paper
- C3
- open access
Association of spontaneous 3-year changes in physical function with subsequent 15-year mortality in community-dwelling older men
-
- Conference Paper
- C3
- open access
Validation of the FNIH sarcopenia criteria and SOF frailty index as predictors for longterm mortality in ambulatory older men
-
Body composition, bone turnover, and bone mass in trans men during testosterone treatment: 1-year follow-up data from a prospective case-controlled study (ENIGI)
-
Preservation of volumetric bone density and geometry in trans women during cross-sex hormonal therapy: a prospective observational study
-
- Conference Paper
- C3
- open access
Change in Timed Up and Go performance over time in community-dwelling older men
-
- Conference Paper
- C3
- open access
Longitudinal performance assessment for predicting adverse outcomes : the added value to single time point Timed Up and Go assessment
-
Effects of tail suspension on serum testosterone and molecular targets regulating muscle mass
-
- Conference Paper
- C3
- open access
Longitudinal performance assessment for predicting adverse outcomes : the added value to single time point Timed Up and Go assessment
-
- Conference Paper
- C3
- open access
Change in timed up and go performance over time in community-dwelling older men
-
- Conference Paper
- C3
- open access
Frailty and health-related quality of life in ambulatory older men
-
- Conference Paper
- C3
- open access
The FNIH-criteria for sarcopenia predict 15-year mortality in ambulatory older men